Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-02

Clinical Trial Update: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [NA]

View source ↗

Summary

This clinical-trial update reports completion and results posting for palifermin used to prevent chronic graft-versus-host disease in patients undergoing donor …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palifermin (palifermin)

Snippet

Sponsor: Martin, Paul | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | NA | Status: COMPLETED | Results posted: 2014-04-02